Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial
Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page
- Check5 days agoChange DetectedA new site revision note 'Revision: v3.4.2' appears; previous notices about government funding delays and 'Revision: v3.4.1' are removed.SummaryDifference0.4%

- Check12 days agoChange DetectedAdded a government funding notice with an NIH operations status update. Updated the site revision to v3.4.1, replacing the previous v3.4.0 note.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page adds a 'Show glossary' option and includes minor metadata edits (such as QC criteria wording and revision notes) that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check33 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded 'Locations' sections for Indiana, Louisiana, Virginia, and Ontario, and removed the corresponding location blocks. The revision note updated to v3.3.3.SummaryDifference0.5%

- Check77 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.